Why We Take Risks - It's the Dopamine
By ALICE PARK
Risk-taking, by definition, defies logic. Reason can't
explain why people do unpredictable things - like betting
on blackjack or jumping out of planes - for little or,
sometimes, no reward at all. There's the thrill, of course,
but those brief moments of ecstasy aren't enough to keep
most risk takers coming back for more - which they do,
again and again, like addicts.
A new study by researchers at Vanderbilt University in
Nashville and Albert Einstein College of Medicine in New
York City suggests a biological explanation for why
certain people tend to live life on the edge - it involves the
neurotransmitter dopamine, the brain's feel-good
chemical. (See the Year in Health, from A to Z.)
Dopamine is responsible for making us feel satisfied after
a filling meal, happy when our favorite football team wins,
or really happy when we use stimulating drugs like
amphetamines or cocaine, which can artificially squeeze
more dopamine out of the nerve cells in our brain. It's also
responsible for the high we feel when we do something
daring, like skiing down a double black diamond slope or
skydiving out of a plane. In the risk taker's brain,
researchers report in the Journal of Neuroscience, there
appear to be fewer dopamine-inhibiting receptors -
meaning that daredevils' brains are more saturated with
the chemical, predisposing them to keep taking risks and
chasing the next high:
driving too fast, drinking too much, overspending or even
taking drugs.
David Zald, a professor of psychology and psychiatry at
Vanderbilt, studied whether the brains of those thrill
seekers differed in any way from those of the less
adventuresome when it comes to dopamine. He gave 34
men and women a questionnaire to assess their novelty-
seeking tendencies, then scanned their brains using a
technique called positron emission tomography to figure
out how many dopamine receptors the participants had. Zald and his team were on the lookout for a particular
dopamine-regulating receptor, which monitors levels of
the neurotransmitter and signals brain cells to stop
churning it out when there's enough.
Earlier studies in rats had shown that animals that tend to
explore and take more risks in new environments also
tend to have fewer of these inhibitory receptors, and Zald
wanted to find out if the same was true in people.
"This is one of those situations where the data came out
essentially perfectly," he says. "The results were exactly
as we predicted they would be, based on the animal
data." That is, like the rats, humans who were more
spontaneous and eager to take risks had fewer
dopamine-regulating receptors than those who were more
cautious.
The findings support Zald's theory that people who take
risks get an unusually big hit of dopamine each time they
have a novel experience, because their brains are not
able to inhibit the neurotransmitter adequately. That blast
makes them feel good, so they keep returning for the rush
from similarly risky or new behaviors, just like the addict
seeking the next high.
"This finding is really interesting," says Dr. Bruce Cohen,
director of the Frazier Research Institute at McLean
Hospital in Boston and a professor of psychiatry at
Harvard Medical School. "It's a piece of the puzzle to
understanding why we like novelty, and why we get
addicted to substances ... Dopamine is an important piece
of reward."
Cohen suggests that a better understanding of novelty-
seeking behavior may even help researchers find more
effective treatments for addiction. If future studies
validate Zald's findings and show that addicts also have
fewer dopamine-inhibiting receptors than average, then
medicines designed to replace the function of those
receptors may help bring their dopamine levels down to
normal and weaken their addiction.
On a more theoretical level, Zald's results may also help
inform a long-ranging debate in the addiction field. Some
experts believe that addicts suffer from a natural deficit of
dopamine and self-medicate with drugs; others think
addicts' brains make normal amounts of the
neurotransmitter but just can't break it down and regulate
it properly.
"We think a person who finds novelty and excitement
more rewarding does so because he gets more dopamine
release, or more of a boost," says Zald. "But it's one of
the big controversies in the field of addiction research
now." And it's yet another area for researchers to explore
in trying to come up with a better treatment for substance
abuse.
See the top 10 scientific discoveries of 2008.
轉貼自︰
http://news.yahoo.com/s/time/20081231/hl_time/08599186910600
(Time)
本文於 修改第 1 次